US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist

5.650
-0.050-0.88%

Close Feb 25 16:00 ET

5.690
+0.040+0.71%

Post 19:48 ET

1.56BMarket Cap70.63P/E (TTM)

MannKind Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MannKind Q4 2024 Estimates Date

Currency：USDFeb 26, 2025

	Estimate	YoY
Revenue	74.99M	+28.26%
EPS	0.03	+637.21%

Analyst Rating

Strong Buy

Feb 12, 2025

MannKind Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 75.406M	--
Feb 26, 2025	2024/Q4	-- / 74.994M	--
Nov 7, 2024	2024/Q3	70.079M / 74.487M	--
Aug 7, 2024	2024/Q2	72.386M / 64.813M	--
May 8, 2024	2024/Q1	66.263M / 60.550M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 75.406M--

Feb 26, 20252024/Q4-- / 74.994M--

Nov 7, 20242024/Q370.079M / 74.487M--

Aug 7, 20242024/Q272.386M / 64.813M--

May 8, 20242024/Q166.263M / 60.550M--

Unlock Free Earnings Estimates

Open Account

MannKind Earnings Reports

MannKind | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:14 ET

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Conference Call to Begin Today at 4:30 p.m. (ET)

Nov 7, 2024 16:08 ET

MannKind | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 08:11 ET

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET)